Results 231 to 240 of about 4,621,962 (301)

Mn(II)-Tagged DOTA-Modified Sugar-Based Biopolymers as Gadolinium-Free Contrast Agents for Magnetic Resonance Imaging. [PDF]

Pharmaceutics
Pashkunova-Martic I, Friske J, Bartsch SJ, Prinz D, Balber T, Pichler V, Baurecht D, Keppler BK, Helbich TH.   +8 more
europepmc   +1 more source

EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors. [PDF]

J Biol Chem
Chen M, Chen J, Ren X, Liu C, Bai C, Wang X, Duan J, Ai S, Yan X, Yang F, Liu X.   +10 more
europepmc   +1 more source

Uptake characteristics of MRI and CT contrast agents in 3D printing materials for vascular phantoms. [PDF]

3D Print Med
Dell AC, Wist C, Grasshoff H, Sieren MM, Buhné MJ, Schareck C, Ulloa P, Buzug TM, Kloeckner R, Barkhausen J, Frydrychowicz A, Friedrich T, Wegner F.   +12 more
europepmc   +1 more source

Spin State Modulation Strategies for Transition Metal-Based MRI Contrast Agents. [PDF]

Chem Biomed Imaging
Chen YX, Ge AW, Guo X, Yu M, Tao J.
europepmc   +1 more source

Manganese-Based Contrast Agents as Alternatives to Gadolinium: A Comprehensive Review. [PDF]

Clin Pract
Poggiarelli L, Bernetti C, Pugliese L, Greco F, Beomonte Zobel B, Mallio CA.   +5 more
europepmc   +1 more source

LHRH-Conjugated Magnetite Nanoparticles and Nanorods as Magnetic Resonance Imaging Contrast Agents for Targeting Triple-Negative Breast Cancer. [PDF]

J Funct Biomater
Ezeala CC, Obayemi JD, Salifu AA, Ezenwafor T, Danyuo Y, Onyekanne MC, Eluu SC, Aina T, Oparah J, Etinosa PO, Odusanya OS, Soboyejo WO.   +11 more
europepmc   +1 more source

Characterization of focal hepatic lesions with Pulse Inversion Harmonic Imaging (PIHI) using a second generation US contrast agent.

, 2001
Locatelli M, QUAIA, Emilio, Stacul F, Pozzi Mucelli R.S., BERTOLOTTO, MICHELE   +4 more
core  

Some of the next articles are maybe not open access.

Related searches:

Contrast Agents

Veterinary Clinics of North America: Small Animal Practice, 1993
Pharmacologic development and clinical use of nonionic low osmolality contrast agents have lowered incidences of contrast reactions. Exclusive use of these agents may be limited owing to their high costs. Ionic high osmolality agents still provide reliable means of positive contrast enhancement, and minimal problems with reactions have been experienced
openaire   +2 more sources

Contrast agents and mechanisms

Drug Discovery Today: Technologies, 2011
MRI contrast agents are routinely used in clinical settings. Important advances in their design have been attained in the past few years to overcome sensitivity issues and to make possible molecular imaging applications by means of this modality. Besides the sensitivity enhancement of paramagnetic relaxation probes, outstanding results have been ...
DASTRU', Walter, LONGO, DARIO LIVIO, AIME, Silvio   +2 more
openaire   +4 more sources